ALPS Advisors’s Zura Bio ZURA Stock Holding History

ALPS Advisors’s Portfolio ZURA Stock Details ZURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$569K	Buy	96,414 +26,222	+37%	+$125K	﹤0.01%	926
2026 Q1	$418K	Buy	70,192 +16,803	+31%	+$102K	﹤0.01%	946
2025 Q4	$280K	Buy	+53,389	New	+$211K	﹤0.01%	945

Other funds holding ZURA

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

ALPS Advisors's ZURA Position: Q2 2026 in Review

ALPS Advisors increased its Zura Bio (ZURA) stake by 37% in Q2 2026, buying an estimated $125K and bringing the position to 96,414 shares worth $569K. The position accounts for ﹤0.01% of the portfolio, ranked #926.

ALPS Advisors first reported a position in ZURA in Q4 2025 and has held it in 3 quarters since. 95 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

ALPS Advisors held 96,414 shares of Zura Bio worth $569K as of Q2 2026.
ALPS Advisors bought 26,222 Zura Bio shares in Q2 2026, an estimated $125K.
Zura Bio made up ﹤0.01% of ALPS Advisors's portfolio in Q2 2026, its #926 holding.
ALPS Advisors first reported a position in Zura Bio in Q4 2025 and has held it in 3 quarters since.
95 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on ALPS Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.